ESIMIDYME Trademark

Trademark Overview

On Thursday, March 7, 2019, a trademark application was filed for ESIMIDYME with the United States Patent and Trademark Office. The USPTO has given the ESIMIDYME trademark a serial number of 88330360. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 7, 2022. This trademark is owned by Genzyme Corporation. The ESIMIDYME trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
esimidyme

General Information

Serial Number88330360
Word MarkESIMIDYME
Filing DateThursday, March 7, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 7, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 24, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenzyme Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameGenzyme Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, November 7, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 7, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, February 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 24, 2022SOU EXTENSION 5 GRANTED
Thursday, February 17, 2022SOU EXTENSION 5 FILED
Thursday, February 24, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 17, 2022TEAS EXTENSION RECEIVED
Saturday, September 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 2, 2021SOU EXTENSION 4 GRANTED
Thursday, September 2, 2021SOU EXTENSION 4 FILED
Thursday, September 2, 2021TEAS EXTENSION RECEIVED
Saturday, February 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 4, 2021SOU EXTENSION 3 GRANTED
Thursday, February 4, 2021SOU EXTENSION 3 FILED
Thursday, February 4, 2021TEAS EXTENSION RECEIVED
Saturday, September 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 3, 2020SOU EXTENSION 2 GRANTED
Thursday, September 3, 2020SOU EXTENSION 2 FILED
Thursday, September 3, 2020TEAS EXTENSION RECEIVED
Thursday, March 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 3, 2020SOU EXTENSION 1 GRANTED
Tuesday, March 3, 2020SOU EXTENSION 1 FILED
Tuesday, March 3, 2020TEAS EXTENSION RECEIVED
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 1, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 6, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 2, 2019ASSIGNED TO LIE
Tuesday, June 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 24, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 24, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 24, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 3, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 3, 2019NON-FINAL ACTION E-MAILED
Wednesday, April 3, 2019NON-FINAL ACTION WRITTEN
Sunday, March 31, 2019ASSIGNED TO EXAMINER
Tuesday, March 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 11, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

esimidyme diseases preparations pharmaceutical treatment prevention namely infectious rare infections bacterial